{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:07:21Z","timestamp":1790060841105,"version":"4.0.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jsat.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T18:57:54Z","timestamp":1466881074000},"page":"117-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review"],"prefix":"10.1016","volume":"72","author":[{"given":"Evan S.","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis K.","family":"Matusiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine L.","family":"Stitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey C.","family":"Sigmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2016.06.009_bb0005","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dld.2010.12.004","article-title":"Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates)","volume":"43","author":"Almasio","year":"2011","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.jsat.2016.06.009_bb0015","first-page":"39","article-title":"Epidemiology and prevention of hepatitis B","volume":"Vol. 23, No. 1","author":"Alter","year":"2003"},{"key":"10.1016\/j.jsat.2016.06.009_bb0020","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/323201","article-title":"Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring","volume":"33","author":"Arnsten","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2016.06.009_bb0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jinf.2009.03.004","article-title":"The emergence of meticillin-resistant Staphylococcus aureus among injecting drug users","volume":"58","author":"Atkinson","year":"2009","journal-title":"Journal of Infection"},{"key":"10.1016\/j.jsat.2016.06.009_bb0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-8716(01)00208-3","article-title":"A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users","volume":"66","author":"Batki","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0035","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/00365529509101616","article-title":"Chronic hepatitis C in alcoholic patients: Prevalence, genotypes, and correlation to liver disease","volume":"30","author":"Befrits","year":"1995","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.jsat.2016.06.009_bb0040","first-page":"96","article-title":"A spoonful of sugar...: improving adherence to tuberculosis treatment using financial incentives [notes from the field","volume":"5","author":"Bock","year":"2001","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jsat.2016.06.009_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0376-8716(99)00094-0","article-title":"Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack","volume":"58","author":"Booth","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0050","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2893.2008.01010.x","article-title":"Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients","volume":"15","author":"Bruggmann","year":"2008","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.jsat.2016.06.009_bb0060","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jsat.2016.06.009_bb0075","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent mycobacterium tuberculosis infection","volume":"48","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2016.06.009_bb0080","article-title":"Monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2014United States and 6 dependent areas\u20142012","volume":"19(No.3)","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"10.1016\/j.jsat.2016.06.009_bb0085","author":"Centers for Disease Control and Prevention"},{"issue":"ss-6","key":"10.1016\/j.jsat.2016.06.009_bb0090","first-page":"1","article-title":"HIV infection and risk, prevention, and testing behaviors among injecting drug users: National HIV behavioral surveillance system, 20 U.S. cities, 2009","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"Morbidity and Mortality Weekly Reports"},{"key":"10.1016\/j.jsat.2016.06.009_bb0095","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jsat.2016.06.009_bb0100","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jsat.2016.06.009_bb0105","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jsat.2016.06.009_bb0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00042560-199604150-00005","article-title":"Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection","volume":"11","author":"Chaisson","year":"1996","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2016.06.009_bb0115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9343(01)00695-7","article-title":"A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users","volume":"110","author":"Chaisson","year":"2001","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0120","first-page":"860","article-title":"The effects of increasing incentives on adherence to tuberculosis directly observed therapy","volume":"4","author":"Davidson","year":"2000","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jsat.2016.06.009_bb0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAD.0b013e3280114a15","article-title":"Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City","volume":"21","author":"Des Jarlais","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jsat.2016.06.009_bb0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1037\/1064-1297.8.2.176","article-title":"Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance","volume":"8","author":"Downey","year":"2000","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2016.06.009_bb0135","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1046\/j.1360-0443.1998.939139310.x","article-title":"Risk factors for and knowledge of mycobacterium tuberculosis infection among drug users in substance abuse treatment","volume":"93","author":"Durante","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.06.009_bb0140","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s10461-013-0416-1","article-title":"A study of financial incentives to reduce plasma HIV RNA among patients in care","volume":"17","author":"Farber","year":"2013","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.jsat.2016.06.009_bb0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.drugalcdep.2004.11.011","article-title":"Do research payments precipitate drug use or coerce participation?","volume":"78","author":"Festinger","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.drugalcdep.2008.02.007","article-title":"Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion","volume":"96","author":"Festinger","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0155","first-page":"153","article-title":"Use of incentives to increase compliance for TB screening in a population of intravenous drug users","volume":"3","author":"FitzGerald","year":"1999","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jsat.2016.06.009_bb0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/COH.0b013e328354bd44","article-title":"Tuberculosis and HIV in people who inject drugs: Evidence for action for tuberculosis, HIV, prison and harm reduction services","volume":"7","author":"Getahun","year":"2012","journal-title":"Current Opinion in HIV and AIDS"},{"key":"10.1016\/j.jsat.2016.06.009_bb0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagen","year":"2001","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2016.06.009_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.11.011","article-title":"Contingency management in substance abuse treatment: A structured review of the evidence for its transportability","volume":"122","author":"Hartzler","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11904-006-0010-5","article-title":"Contingency management interventions for HIV-related behaviors","volume":"3","author":"Haug","year":"2006","journal-title":"Current HIV\/AIDS Reports"},{"key":"10.1016\/j.jsat.2016.06.009_bb0180","series-title":"Contingency Management in Substance Abuse Treatment","year":"2008"},{"key":"10.1016\/j.jsat.2016.06.009_bb0185","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1086\/343827","article-title":"Crack cocaine use and other risk factors for tuberculin positivity in drug users","volume":"35","author":"Howard","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2016.06.009_bb0190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.qai.0000243090.32866.4e","article-title":"The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: Evidence of continuing racial and ethnic differences","volume":"43","author":"Hutchinson","year":"2006","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2016.06.009_bb0195","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1086\/656776","article-title":"Accelerated hepatitis B vaccination schedule among drug users: A randomized controlled trial","volume":"202","author":"Hwang","year":"2010","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.jsat.2016.06.009_bb0200","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1306227","article-title":"Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1","volume":"370","author":"Kowdley","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0205","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(00)04562-1","article-title":"Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis","volume":"357","author":"Kral","year":"2001","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2016.06.009_bb0210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s15010-011-0241-2","article-title":"Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the behavioral risk factor surveillance survey, 2007","volume":"40","author":"Ladak","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.jsat.2016.06.009_bb0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","article-title":"A meta-analysis of voucher-based reinforcement therapy for substance use disorders","volume":"101","author":"Lussier","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.06.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007952.pub2","article-title":"Material incentives and enablers in the management of tuberculosis","volume":"1","author":"Lutge","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2016.06.009_bb0225","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2105\/AJPH.88.5.792","article-title":"Tuberculosis screening and compliance with return for skin test reading among active drug users","volume":"88","author":"Malotte","year":"1998","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2016.06.009_bb0230","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0749-3797(98)00093-2","article-title":"Monetary versus nonmonetary incentives for TB skin test reading among drug users","volume":"16","author":"Malotte","year":"1999","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0749-3797(00)00283-X","article-title":"Incentives vs outreach workers for latent tuberculosis treatment in drug users","volume":"20","author":"Malotte","year":"2001","journal-title":"American Journal of Preventive Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2016.06.009_bb0094","first-page":"1","article-title":"Statement Online","volume":"15","author":"Management of Hepatitis C. NIH Consens","year":"1997","journal-title":"1997 Mar 24-26"},{"issue":"1","key":"10.1016\/j.jsat.2016.06.009_bb9005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","article-title":"Survival rate and risk factors of mortality among HIV\/tuberculosis-coinfected patients with and without antiretroviral therapy","volume":"43","author":"Manosuthi","year":"2006","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.jsat.2016.06.009_bb0240","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/QAD.0000000000000613","article-title":"The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs","volume":"29","author":"Martin","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.jsat.2016.06.009_bb0245","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10550490290088072","article-title":"Modified directly observed therapy (MDOT) for injection drug users with HIV disease","volume":"11","author":"McCance-Katz","year":"2002","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2016.06.009_bb0250","series-title":"Preventing HIV transmission: The role of sterile needles and bleach","year":"1995"},{"key":"10.1016\/j.jsat.2016.06.009_bb0255","author":"National Institute on Drug Abuse"},{"key":"10.1016\/j.jsat.2016.06.009_bb0260","author":"National Institute on Drug Abuse"},{"key":"10.1016\/j.jsat.2016.06.009_bb0265","author":"National Institute on Drug Abuse"},{"issue":"9791","key":"10.1016\/j.jsat.2016.06.009_bb9010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2016.06.009_bb0270","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2105\/AJPH.83.12.1743","article-title":"Nemesis revisited: Tuberculosis infection in a New York City men's shelter","volume":"83","author":"Paul","year":"1993","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2016.06.009_bb0275","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/jurban\/jtg044","article-title":"Impact of monetary incentives on adherence to referral for screening chest X-rays after syringe exchange-based tuberculin skin testing","volume":"80","author":"Perlman","year":"2003","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.jsat.2016.06.009_bb0280","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3201\/eid1703.101002","article-title":"Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003\u20132009","volume":"17","author":"Perri","year":"2011","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.jsat.2016.06.009_bb0285","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1258\/0956462991914654","article-title":"Alcohol use in HIV patients: What we don't know may hurt us","volume":"10","author":"Petry","year":"1999","journal-title":"International Journal of STD & AIDS"},{"key":"10.1016\/j.jsat.2016.06.009_bb0290","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0376-8716(03)00090-5","article-title":"Discounting of money, health, and freedom in substance abusers and controls","volume":"71","author":"Petry","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2016.06.009_bb9015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.2003.00642.x","article-title":"Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?","volume":"99","author":"Petry","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.06.009_bb0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.1996.00440020063008","article-title":"Tuberculosis prophylaxis in the homeless: A trial to improve adherence to referral","volume":"156","author":"Pilote","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0305","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.ypmed.2011.11.015","article-title":"Promoting healthy behaviours and improving health outcomes in low and middle income countries: A review of the impact of conditional cash transfer programmes","volume":"55","author":"Ranganathan","year":"2012","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0310","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-9-450","article-title":"The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review","volume":"9","author":"Rehm","year":"2009","journal-title":"BMC public health"},{"key":"10.1016\/j.jsat.2016.06.009_bb0315","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/FBP.0b013e3280115f99","article-title":"A review of delay-discounting research with humans: Relations to drug use and gambling","volume":"17","author":"Reynolds","year":"2006","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.jsat.2016.06.009_bb0320","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1046\/j.1525-1497.2000.00127.x","article-title":"Cue-dose training with monetary reinforcement: Pilot study of an antiretroviral adherence intervention","volume":"15","author":"Rigsby","year":"2000","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0325","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0163-4453(99)90006-3","article-title":"Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: Adherence, side effects and efficacy","volume":"39","author":"Roca","year":"1999","journal-title":"Journal of Infection"},{"key":"10.1016\/j.jsat.2016.06.009_bb0330","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0376-8716(99)00073-3","article-title":"A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar","volume":"58","author":"Roll","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0335","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1901\/jaba.1996.29-495","article-title":"An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar","volume":"29","author":"Roll","year":"1996","journal-title":"Journal of Applied Behavior Analysis"},{"key":"10.1016\/j.jsat.2016.06.009_bb0340","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(03)00074-7","article-title":"A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users","volume":"71","author":"Seal","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0345","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s002130051098","article-title":"Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcement magnitude","volume":"146","author":"Silverman","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsat.2016.06.009_bb0350","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu324","article-title":"Voucher incentives improve linkage to and retention in care among HIV-infected drugs users in Chennai, India","author":"Solomon","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2016.06.009_bb0355","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugalcdep.2006.09.019","article-title":"Voucher reinforcement improves medication adherence in HIV-positive methadone patients: A randomized trial","volume":"88","author":"Sorensen","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0360","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.clinpsy.2.022305.095219","article-title":"Contingency management for treatment of substance abuse","volume":"2","author":"Stitzer","year":"2006","journal-title":"Annual Review Clinical Psychology"},{"key":"10.1016\/j.jsat.2016.06.009_bb0365","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugalcdep.2009.09.006","article-title":"Drug users' adherence to a 6-month vaccination protocol: Effects of motivational incentives","volume":"107","author":"Stitzer","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.06.009_bb0370","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1257\/aer.98.5.1829","article-title":"The demand for, and impact of, learning HIV status","volume":"98","author":"Thornton","year":"2008","journal-title":"The American Economic Review"},{"key":"10.1016\/j.jsat.2016.06.009_bb0375","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ypmed.2013.04.013","article-title":"A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia","volume":"57","author":"Topp","year":"2013","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0380","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2105\/AJPH.90.3.447","article-title":"Vaccination strategies for targeted and difficult-to-access groups","volume":"90","author":"Trubatch","year":"2000","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2016.06.009_bb0385","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.160.5.697","article-title":"Adherence to isoniazid prophylaxis in the homeless: A randomized controlled trial","volume":"160","author":"Tulsky","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2016.06.009_bb0390","first-page":"83","article-title":"Can the poor adhere? Incentives for adherence to TB prevention in homeless adults","volume":"8","author":"Tulsky","year":"2004","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jsat.2016.06.009_bb0400","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1037\/1064-1297.15.4.338","article-title":"Contingency management in cocaine abusers: A dose-effect comparison of goods-based versus cash-based incentives","volume":"15","author":"Vandrey","year":"2007","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2016.06.009_bb0405","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(14)60196-3","article-title":"Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: A cluster randomised trial","volume":"384","author":"Weaver","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2016.06.009_bb0410","first-page":"506","article-title":"A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail","volume":"2","author":"White","year":"1998","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.jsat.2016.06.009_bb0415","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archinte.162.9.1044","article-title":"Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail","volume":"162","author":"White","year":"2002","journal-title":"Archives of Internal Medicine"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216300423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216300423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:45:17Z","timestamp":1760039117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216300423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":82,"alternative-id":["S0740547216300423"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2016.06.009","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}